tirzepatide and wegovy Diabetes drug linked to more significant weight loss than semaglutide Weight loss drugs like Mounjaro

Zepbound (tirzepatide) is FDA-approved for chronic weight management in eligible adults, providing a clinically studied option for sustained fat reduction

What does this FDA decision regarding tirzepatide mean for patients and providers

H., Burns, J

Kusminski CM, Porez-Tilvo D, Muller TD, DiMarchi RD, Tschop MH, Scherer PE

Authorship All named authors meet the International Committee of Medical Journal Editors criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published

This set of data is adequate as baseline evidence for the cardiovascular safety of tirzepatide, but a specific and longer clinical trial (SURPASS CVOT) is currently being conducted to give definite answers on the possible cardiovascular protective factor of tirzepatide [26]